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Abstract
Background: Three decades after US and Australian forces withdrew from Vietnam, there has
been much public interest in the health consequences of service in Vietnam. One controversial
question is whether the risk of prostate cancer amongst Vietnam veterans is increased. This paper
examines relationships between military history, family history and risk of prostate cancer in a
population-based case control study.
Methods: Cases were selected from the Cancer Registry of Western Australia as incident cases
of histologically-confirmed prostate cancer, and controls were age-matched and selected from the
Western Australian electoral roll. Study participants were asked to report any military service
history and details about that service.
Results: Between January 2001 and September 2002, 606 cases and 471 controls aged between
40–75 years were recruited. An increased prostate cancer risk was observed in men reporting they
were deployed in Vietnam although this was not statistically significant (OR = 2.12; 95% CI 0.88–
5.06). An increased risk was also observed in men reporting prostate cancer in fathers (OR = 1.90;
95% CI 1.20–3.00) or brothers (OR = 2.05; 95% CI 1.20–3.50) diagnosed with prostate cancer.
Conclusion: These findings support a positive association between prostate cancer and military
service history in the Vietnam war and a first degree relative family history of prostate cancer.
Background
For more than two decades the perceived ill-health of Viet-
nam veterans has been a public issue in Australia. As part
of the Allied Forces in Vietnam, over 50 000 Australians
served from 1964–1972, with approximately 500 losing
their lives and nearly 2500 wounded [1]. Vietnam veter-
ans have been studied in Australia and elsewhere, in an
attempt to explain how service-related experience may
affect their health and well-being in both the short and
long-term [2].
In 1998 the Australian Institute of Health and Welfare [2]
surveyed male Vietnam veterans regarding their current
health problems [3]. Medical confirmation of some of
these self-reported medical conditions was attempted in
1999 [2]. A higher prevalence of several conditions
(including prostate cancer) was found in Vietnam veter-
ans compared to the Australian community standard [2].
In this study, we aimed to use a case-control design to
examine whether service in the Vietnam war may be asso-
ciated with an increased prostate cancer risk after adjust-
ing for known risk factors such as age and family history.
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We used data from a population based case-control study
undertaken in Perth, Western Australia during 2001–
2002.
Cases were men between the ages of 40 and 75 years with
prostate cancer, histologically confirmed between January
1, 2001 and August 30, 2002. Cases were identified from
the Cancer Registry of Western Australia. Cancer reporting
by pathologists is mandatory in Western Australia.
Permission was sought from each case's urologist before
approaching the patient to participate in the study. Dur-
ing the study period we identified 1226 apparently-eligi-
ble prostate cancer cases and excluded 166. Reasons for
exclusion included; case did not have a Western Austral-
ian contact address; admitting doctor and/or operating
doctor and/or separation doctor could not be identified;
or urologist did not reply. Of the 1066 men invited to be
in the study 685 (64%) of cases gave their consent to be in
the study. Cases for which the doctor refused permission
were slightly more likely to be urban residents but had a
similar age distribution to the cases for which we had per-
mission to approach. Of those approached, there were no
differences in age and rural/urban residence between par-
ticipants and non-participants.
Controls were randomly selected from men aged 40–75
years, without a history of prostate cancer, and who were
currently enrolled on the Electoral Roll of Western Aus-
tralia. The controls were frequency matched to the
expected case distribution within 5-year age groups. Of
the 1272 controls invited to participate in the study, 547
(43%) gave their consent. We had no data on non-partic-
ipating controls.
All study participants gave their informed consent before
participating. The study was approved by the Ethics Com-
mittee of the University of Western Australia and the Con-
fidentiality of Health Information Committee,
Department of Health, Western Australia.
Eligible subjects received a reminder card if they had not
returned their consent form within 21 days.
Consenting subjects were required to complete a self-
administered questionnaire on personal demographic fac-
tors; family cancer history; screening history and occupa-
tional history. Subjects were asked to report if they had
ever been a member of the military or national defence
service as a regular or reserve member, and if yes, if they
were ever deployed in an area of conflict. If they had been
deployed in an area of conflict they were also asked to
Table 1: Characteristics of prostate cancer cases and controls
Cases n = 560 N(%) Controls n = 450 N(%) p-value
Age group (years)
50 and under 16 (2.9) 11 (2.4) p < 0.00
51–55 67 (12) 17 (3.8)
56–60 106 (18.9) 61 (13.6)
61–65 126 (22.5) 122 (27.1)
66–69 139 (24.8) 132 (29.3)
70 and above 106 (18.9) 107 (23.8)
Father with prostate cancer
Yes 70 (12.5) 29 (6.4) 0.00
No 490 (87.5) 421 (93.6)
Brother with prostate cancer
Has brother No Cap 358 (63.9) 316 (70.2) 0.03
Has brother, Has CaP 47 (8.4) 22 (4.9)
No brother 155 (27.7) 112 (24.9)
Served in military
Yes 227 (40.5) 179 (39.8) 0.80
No 333 (59.5) 271 (60.2)
Area Served
Vietnam
Yes 25 (4.5) 7 (1.6) 0.00
No 535 (95.5) 443 (98.4)
Korea
Yes 4 (.7) 8 (1.6) 0.12
No 556 (99.3) 442 (98.2)
South East (SE) Asia
Yes 43 (7.7) 31 (6.9) 0.63
No 517 (92.3) 419 (93.1)Page 2 of 6
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deployment; country or region of deployment; job title;
rank; unit/ship/squadron name.
The Gleason's score assigned at the time of prostate cancer
diagnosis was collected for each case from the pathology
reports held by the Cancer Registry of Western Australia.
The Gleason's score is a grading dependent on the histo-
logical architecture of the prostate cancer cell, and has
been reported as the most valuable prognostic factor for
prostate cancer cases [4]. The highest score possible is 10,
indicating more aggressive disease and possibly a poor
prognosis. 'Aggressive prostate cancer' was defined by a
Gleason's score of greater than or equal to 7.
Data were analysed using contingency tables and chi-
squared tests. Logistic regression was performed to calcu-
late odds ratios (OR) and 95% confidence intervals (CI)
for the risk of prostate cancer by family history and mili-
tary service after adjusting for the effect of age. Data were
analysed by statistical software package SPSS11 for Win-
dows. We repeated the analyses restricting the prostate
cancer cases to those with a Gleason's score of greater than
or equal to 7.
Results
Cases and controls were reasonably well matched by age
(Table 1). Cases were more likely to report fathers or
brothers with prostate cancer (Table 1). Family history
had a significant positive association with prostate cancer.
Having a father or brother with prostate cancer almost
doubled the risk of prostate cancer (Table 2). Similarly,
family history had an increased effect in the aggressive
prostate cancer group, for a father with a history of pros-
tate cancer the OR was 2.09; (95% CI 0.87 – 5.00) and for
a brother with prostate cancer the OR was 2.13; (95% CI
0.89 – 5.10).
A history of military service, or service in an area of con-
flict did not increase the risk of prostate cancer (Table 1
and Table 2). However, having served in Vietnam almost
doubled the risk of prostate cancer, although this was not
statistically significant. After adjusting for family history,
the risk of prostate cancer in those serving in Vietnam was
2.08; (95% CI 0.87 – 5.01). When the analysis was
restricted to those with aggressive prostate cancer the
results were similar with an OR of 2.09; (95% CI 0.79 –
5.49).
Of the Vietnam veterans in our study, 76.5% were Austral-
ian Regular Army (ARA) personnel; 17.6% Royal Austral-
ian Navy (RAN) personnel and 5.9% in the Royal
Australian Air Force (RAAF). The most common serving
rank was Private 29.4%, followed by Corporal 23.5% and
Sergeant 17.6%. The other ranks were comprised of lance-
corporal, leading aircraftsmen, warrant officer and cap-
tain. The average age of Vietnam veterans was 58.0 years,
the average of non-Vietnam veterans was 65.0 years. The
age range of veterans was between 50–74 years.
With regard to experiences after Vietnam there were no
differences between Vietnam veterans who did or did not
develop cancer with regard to country of birth, smoking
status, body mass index, alcohol intake, years spent in
farming or driving vehicles, or occupational physical
activity.
Discussion
This population based case-control study has confirmed
that a family history among first degree relatives is an
important risk factor for prostate cancer, and suggests that
service in the Vietnam war is also a risk factor for prostate
cancer (although this finding did not reach statistical sig-
nificance).
The role of family history is one of the few factors that do
have a consistent positive association with prostate cancer
[5]. Almost universally studies using different study
designs including hospital based and population based
case-control, cross sectional, family and cohort studies
Table 2: Odds ratios (OR) and 95% confidence intervals (CI) for risk of prostate cancer in relation to family history and military combat 
history (all adjusting for age).
OR* 95% CI p-value
Family History
Father with prostate cancer 1.90 1.20–3.00 0.007
Brother with prostate cancer 2.05 1.20–3.50 0.008
Served in military 1.14 0.88 – 1.48 0.33 
Served in an area of conflict 1.05 0.67 – 1.64 0.83
Served in Vietnam 2.12 0.88 – 5.06 0.09
Served in Korea 0.48 0.14 – 1.63 0.24
Served in SE Asia 1.01 0.62 – 1.66 0.96Page 3 of 6
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first degree relative is associated with at least a doubling of
risk among relatives [6-11] similar to our finding.
Several limitations of our data on family history are
acknowledged. Firstly, family history data was collected
by self reports which were not verified. However self
report of prostate cancer in first degree relatives has been
shown to be relatively accurate [5,6]. Selection bias may
also have occurred if controls with a family history of
prostate cancer were more likely to participate in the case-
control study. Recall bias may also have occurred, as cases
may differentially report their family history compared
with healthy controls.
In addition, the level of screening in the Australian popu-
lation is an area of interest to note. In the early 1990s the
incidence of prostate cancer dramatically increased after
the introduction of widespread use of prostate-specific
antigen (PSA) testing became fashionable in Australia
[12-14]. These increases may have had an affect on the
reporting of family history of prostate cancer [14].
Our analysis suggests a doubling of prostate cancer risk
among Vietnam War veterans. However this result was not
statistically significant and was based on small numbers
of Vietnam veterans (n = 34). These results are consistent
with the findings of the Australian veterans study [2]
which validated veterans self-report of prostate cancer
with the national cancer registry. It found 212 confirmed
cases of prostate cancer as compared with 147 expected
cases [2], which equates to a standardized incidence ratio
of 144. One proposed causative factor for the increase in
prostate cancer is exposure to herbicides from a US oper-
ation known as 'Ranch Hand'. Nearly 19 million gallons
of herbicide were sprayed on approximately 3.6 million
acres of Vietnamese land [15]. Spraying began in 1962,
intensified in 1967 and was believed to be stopped in
1971 [16]. During the operation a variety of herbicide for-
mulations were used, however most were mixtures of phe-
noxy herbicides, 2,4-dichlorophenoxyacteic acid (2,4-d)
and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) [15,17].
This herbicide was shipped out in drums with orange
stripes, and so it was called Agent Orange [15].
The Center for Disease Control (CDC) proposed three
efforts to assess the health of Vietnam veterans in the
1980's including a historical cohort study that compared
9324 Vietnam Army veterans with 8989 Vietnam-era
Army veterans that served elsewhere [18] and a related
population based case-control study using incident cases
from eight cancer registries [15]. However, the overall
numbers of subjects in these studies with substantial her-
bicide exposure were too small to support firm conclu-
sions [15,18,19].
In a cohort of Australian national service conscripts, cause
of death classes for deaths among 19 205 veterans of the
Vietnam conflict were compared to 25 677 veterans who
only served in Australia. Of 260 deaths, thirty three were
due to neoplasms [20]. There was no statistically signifi-
cant difference between the two groups in death rates
from neoplasms, nor were deaths from specific neoplasms
more frequent among the group that served in Vietnam
[20]. However this study was limited by the relatively brief
follow-up period and the young age of the Vietnam vet-
eran population and a follow-up study at a more relevant
time was recommended [15,17,20]. Most of our subjects
were in over 55 and thus are in the age-groups of most
interest for any cancers that may have been induced by
exposure in Vietnam [21].
One of the challenges in assessing the health outcomes of
the Vietnam conflict is quantifying the exposure. There is
little precise information about how much exposure or
even what herbicides any individual was exposed to and
no standardised methods are available for estimating the
extent of the exposure on an individual level [15,22,23].
Other combat exposures such as infectious diseases and
stress are also difficult to measure [22].
Of the veterans in our study that served in Vietnam, most
were army personnel. The literature suggests that mem-
bers of the US Army Chemical Corps, who stored and
mixed herbicides are thought to have had the heaviest
exposures; members of the Special Forces units who defo-
liated remote campsites; and members of Navy river units
may also have had heavy exposures [15,22]. Australian
troops tended to be confined to the Phoc Tuy Province
which was not heavily sprayed [24].
Because of the limitations of the Vietnam veteran studies,
indirect sources provide an important secondary source
on the potential carcinogenicity of Agent Orange expo-
sure. These include studies on Vietnamese soldiers
exposed to the same herbicides; occupationally exposed
workers in a variety of settings; people exposed after
industrial accidents. On review of this literature, Frumkin
(2003) suggested the evidence of an association between
Agent Orange and prostate cancer is not strong.
In Australia the Department of Veterans Affairs (DVA) is
responsible for providing health care to Australian veter-
ans, including veterans who served in Vietnam [25]. Prior
to the mid 1990's Australian Vietnam veterans received
most of their health care in hospitals that were govern-
ment owned and operated [26]. The veterans' health
scheme now funds, rather than provides directly treat-
ment by general practitioners, specialists, hospitals and
allied health providers [25]. Some co-payments are
required for high end dental and optical treatment [25].Page 4 of 6
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resent the best mix for an individuals' circumstance. Vet-
eran status should not represent any distinct access or
financial advantage over the general population in Aus-
tralia who have access to a health care system which is a
public-private mix.[25]
Strengths of our study include the use of a population-
based cancer registry and pathologically-confirmed cases
of prostate cancer. Further, the military history data we
collected were detailed and not the sole focus of the self-
administered questionnaire. The accuracy of self reported
combat exposure and deployment in an area of conflict
has been reported to be consistent amongst men who
have held a tactical military occupational specialty,
amongst those assigned to combat units and amongst
those who served in Vietnam [22].
A limitation of this study was the low response from eligi-
ble participants. Only 64% of the eligible cases and 43%
of eligible controls agreed to participate in this study.
However, this response rate for controls is consistent with
other recently conducted studies of Australian men and
prostate cancer [12,27,28]. There did not appear to be
major biases in the selection of cases, but we were unable
to examine selection bias in the selection of controls.
Conclusion
A family history of prostate cancer is an important risk fac-
tor amongst first degree relatives, and this confirms earlier
studies [6-11].
The risk of prostate cancer appears to be increased among
men who were deployed as military personnel in the Viet-
nam War after adjusting for age and family history. Given
the number of men deployed, this has possible ramifica-
tions in terms of the number of prostate cases still to
occur, compensation for illness, and burden on the health
care system.
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